[关键词]
[摘要]
胃肠疾病是消化系统中发病率较高的疾病类群,其病因多样且病理机制复杂。藏医在胃肠病的病因、分型和诊治方面具有完善的理论体系和丰富的临床实践经验。仁青常觉、坐珠达西、仁青芒觉等藏医经典方剂在慢性胃炎、消化性溃疡、溃疡性结肠炎、功能性消化不良及结直肠癌等疾病治疗中积累了大量现代临床实证。现代药理学研究表明,藏药复方及药材可通过抑制炎症反应、抗氧化应激、平衡能量代谢、抑制肿瘤细胞增殖、重塑肠道微生态、调节胃肠运动功能等方面发挥胃肠保护作用。通过归纳总结现有研究报道,从藏医疾病分型、临床应用及药理研究方面系统梳理藏药防治胃肠疾病现代研究进展,为临床价值导向的藏药新药创制提供参考。
[Key word]
[Abstract]
Gastrointestinal diseases are a group of disorders with high morbidity within the digestive system, characterized by diverse etiologies and complex pathological mechanisms. Tibetan medicine possesses a comprehensive theoretical framework as well as extensive clinical practical experience in the etiology, classification, diagnosis, and treatment of gastrointestinal diseases. Classical Tibetan medical formulas such as Renqing Changjue, Zuozhu Daxi, and Renqing Mangjue have accumulated a wealth of modern clinical evidence supporting their efficacy in treating conditions including chronic gastritis, peptic ulcer disease, ulcerative colitis, functional dyspepsia, and colorectal cancer. Modern pharmacological studies have demonstrated that Tibetan compound formulas and medicinal materials could exert gastroenteroprotective effects by inhibiting inflammatory responses, mitigating oxidative stress, balancing energy metabolism, suppressing tumor cell proliferation, remodeling the gut microbiota, and modulating gastrointestinal motility. The article synthesizes existing research reports to systematically review the recent advances in modern research on Tibetan medicinal herbs for the prevention and treatment of gastrointestinal disorders in terms of disease classification in Tibetan medicine, clinical applications and pharmacological studies, with the aim of providing a reference for the development of novel Tibetan medicinal drugs oriented toward clinical value.
[中图分类号]
R285
[基金项目]
国家自然科学基金资助项目(82004069); 四川省重点研发项目(2024YFFK0183); 西南民族大学中央高校基本科研业务费专项(ZYN2024035)